结肠癌风险适应性治疗时代的影像学。
Imaging in the era of risk-adapted treatment in colon cancer.
机构信息
Department of Radiology, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.
GROW School for Oncology and Reproduction, Maastricht University Medical Centre, Maastricht, The Netherlands.
出版信息
Br J Radiol. 2024 Jun 18;97(1159):1214-1221. doi: 10.1093/bjr/tqae061.
Abstract
The treatment landscape for patients with colon cancer is continuously evolving. Risk-adapted treatment strategies, including neoadjuvant chemotherapy and immunotherapy, are slowly finding their way into clinical practice and guidelines. Radiologists are pivotal in guiding clinicians toward the most optimal treatment for each colon cancer patient. This review provides an overview of recent and upcoming advances in the diagnostic management of colon cancer and the radiologist's role in the multidisciplinary approach to treating colon cancer.
摘要
结肠癌患者的治疗领域正在不断发展。风险适应治疗策略，包括新辅助化疗和免疫治疗，正在慢慢进入临床实践和指南。放射科医生在为每位结肠癌患者提供最佳治疗方面起着关键作用。本文综述了结肠癌诊断管理方面的最新进展和未来发展方向，以及放射科医生在结肠癌多学科治疗方法中的作用。
相似文献
1
Imaging in the era of risk-adapted treatment in colon cancer.
Br J Radiol. 2024 Jun 18;97(1159):1214-1221. doi: 10.1093/bjr/tqae061.
2
The radiologist's role in the multidisciplinary team for patients with colon cancer peritoneal metastases.
Surg Oncol. 2022 Mar;40:101690. doi: 10.1016/j.suronc.2021.101690. Epub 2021 Nov 24.
3
Colon cancer biology and treatment in the era of precision oncology: A primer for Radiologists.
Eur J Radiol. 2025 Apr;185:112000. doi: 10.1016/j.ejrad.2025.112000. Epub 2025 Feb 13.
4
Narrative review of neoadjuvant therapy in patients with locally advanced colon cancer.
Kaohsiung J Med Sci. 2025 Feb;41(2):e12926. doi: 10.1002/kjm2.12926. Epub 2024 Dec 24.
5
Colon cancer - neoadjuvant treatment of non-metastatic disease.
Rozhl Chir. 2025;104(3):97-100. doi: 10.48095/ccrvch202597.
6
Preoperative Strategies for Locally Advanced Colon Cancer.
Curr Treat Options Oncol. 2024 Mar;25(3):376-388. doi: 10.1007/s11864-024-01184-6. Epub 2024 Feb 13.
7
A watch-and-wait approach for metachronous multiple colon cancer following neoadjuvant immunotherapy: a case report.
Front Immunol. 2024 Oct 4;15:1391038. doi: 10.3389/fimmu.2024.1391038. eCollection 2024.
8
CT Colonography in Preoperative Staging of Colon Cancer: Evaluation of FOxTROT Inclusion Criteria for Neoadjuvant Therapy.
AJR Am J Roentgenol. 2019 Jan;212(1):94-102. doi: 10.2214/AJR.18.19928. Epub 2018 Nov 13.
9
Research Perspective on: Systematic Review of Neoadjuvant Immunotherapy for Mismatch Repair-Deficient Locally Advanced Colon Cancer: An Emerging Strategy.
Dis Colon Rectum. 2024 Jun 1;67(6):772. doi: 10.1097/DCR.0000000000003325. Epub 2024 May 2.
10
Radiologic T staging of colon cancer: renewed interest for clinical practice.
Abdom Radiol (NY). 2023 Sep;48(9):2874-2887. doi: 10.1007/s00261-023-03904-2. Epub 2023 Jun 5.
引用本文的文献
1
Diagnostic accuracy of CT for identifying high-risk colon cancer: a systematic review and meta-analysis.
Eur Radiol. 2025 Aug 16. doi: 10.1007/s00330-025-11844-2.
本文引用的文献
1
MRI in addition to CT in patients scheduled for local therapy of colorectal liver metastases (CAMINO): an international, multicentre, prospective, diagnostic accuracy trial.
Lancet Oncol. 2024 Jan;25(1):137-146. doi: 10.1016/S1470-2045(23)00572-7. Epub 2023 Dec 8.
2
Diagnostic accuracy of CT for local staging of colon cancer: A nationwide study in the Netherlands.
Eur J Cancer. 2023 Nov;193:113314. doi: 10.1016/j.ejca.2023.113314. Epub 2023 Aug 25.
3
Combined Hepatic Arterial Infusion Pump and Systemic Chemotherapy in the Modern Era for Chemotherapy-Naive Patients with Unresectable Colorectal Liver Metastases.
Ann Surg Oncol. 2023 Dec;30(13):7950-7959. doi: 10.1245/s10434-023-14073-3. Epub 2023 Aug 28.
4
Phase I study of intraperitoneal irinotecan combined with palliative systemic chemotherapy in patients with colorectal peritoneal metastases.
Br J Surg. 2023 Oct 10;110(11):1502-1510. doi: 10.1093/bjs/znad228.
5
Efficacy and Safety of Intraoperative Hyperthermic Intraperitoneal Chemotherapy for Locally Advanced Colon Cancer: A Phase 3 Randomized Clinical Trial.
JAMA Surg. 2023 Jul 1;158(7):683-691. doi: 10.1001/jamasurg.2023.0662.
6
Colon cancer CT staging according to mismatch repair status: Comparison and suggestion of imaging features for high-risk colon cancer.
Eur J Cancer. 2022 Oct;174:165-175. doi: 10.1016/j.ejca.2022.06.060. Epub 2022 Aug 24.
7
Diagnostic performance of [F]-FDG PET/MR in evaluating colorectal cancer: a systematic review and meta-analysis.
Eur J Nucl Med Mol Imaging. 2022 Oct;49(12):4205-4217. doi: 10.1007/s00259-022-05871-0. Epub 2022 Jun 16.
8
The Application and Value of 3T Magnetic Resonance Imaging in the Display of Pulmonary Nodules.
Front Oncol. 2022 May 18;12:844514. doi: 10.3389/fonc.2022.844514. eCollection 2022.
9
Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study.
Lancet Oncol. 2022 May;23(5):659-670. doi: 10.1016/S1470-2045(22)00197-8. Epub 2022 Apr 12.
10
Diagnostic performance of MRI for staging peritoneal metastases in patients with colorectal cancer after neoadjuvant chemotherapy.
Eur J Radiol. 2022 Apr;149:110225. doi: 10.1016/j.ejrad.2022.110225. Epub 2022 Feb 19.
Zotero 插件